Xuehui Wang

573 citations
34 papers · 355 indexed · h-index 11
Topics
Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers)Asthma and respiratory diseases (4 papers)Respiratory and Cough-Related Research (3 papers)

In The Last Decade

Xuehui Wang

28 papers receiving 350 citations

Peers

Xuehui Wang
Comparison fields: 5 of 85
  • Molecular Biology 106
  • Cardiology and Cardiovascular Medicine 78
  • Pulmonary and Respiratory Medicine 78
  • Complementary and alternative medicine 51
  • Immunology 50
Replace Jiling Ren with:
Jiling Ren China
Xiang Huang China
Yingqi Zhu China
Huimin Li China
Ge Li‐Sha China
Wenting Lu China
Jiangtao Sheng China
Yohei Abe Japan
Xuehui Wang relative to Jiling Ren China Jiling Ren's profile →
Citations per field
00.5×4.4×
Jiling Ren · 1×
Citations per year

Countries citing papers authored by Xuehui Wang

Since Specialization
Citations

This map shows the geographic impact of Xuehui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehui Wang more than expected).

Fields of papers citing papers by Xuehui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuehui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehui Wang. The network helps show where Xuehui Wang may publish in the future.

Co-authorship network of co-authors of Xuehui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuehui Wang. A scholar is included among the top collaborators of Xuehui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuehui Wang. Xuehui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 3
4 3
5 2
6 16
7 2
8 2
9 10
10 1
11 23
12 6
13 11
14 49
15 2
16 6
17 30
18 33
19 9
20 38

About Xuehui Wang

Xuehui Wang is a scholar working on Energy Engineering and Power Technology, Complementary and alternative medicine and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 355 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (4 papers) and Respiratory and Cough-Related Research (3 papers). The work is most often cited by research in Complementary and alternative medicine (51 citations), Cardiology and Cardiovascular Medicine (78 citations) and Geriatrics and Gerontology (11 citations). Xuehui Wang has collaborated with scholars based in China, United Kingdom and Switzerland. Frequent co-authors include Libo Wang, Xing Li, Ajay M. Shah, Xiaozhen Zhuo, Yu‐An Ding, Lei He, Guoan Zhao, Min Zhang, Aiqun Ma and Yufan Wang. Their work appears in journals such as Scientific Reports, Medicine and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026